According to new clinical trial results, two drugs were able to make breathing easier among IPF or idiopathic pulmonary fibrosis sufferers. Nintedanib and Pirfenidone might be available in the market in 2015.
Nintedanib, Pirfenidone cancer drugs give hope to patients battling idiopathic pulmonary fibrosis
Tech Times - 20 May 2014 08:35
According to new clinical trial results, two drugs were able to make breathing easier among IPF or idiopathic pulmonary fibrosis sufferers. Nintedanib and Pirfenidone might be available in the market in 2015.
Share this Article
Recommended